Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice

被引:0
|
作者
Pamela J. Skinner
Cynthia A. Vierra-Green
Effat Emamian
Huda Y. Zoghbi
Harry T. Orr
机构
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Department of Genetics, Cell and Developmental Biology
[3] University of Minnesota,Institute of Human Genetics
[4] Baylor College of Medicine,Departments of Pediatrics, and Molecular and Human Genetics, Howard Hughes Medical Institute
来源
NeuroMolecular Medicine | 2002年 / 1卷
关键词
ataxia; polyglutamine; SCA1; disease progression;
D O I
暂无
中图分类号
学科分类号
摘要
Spinocerebellar ataxia type 1 (SCA1) belongs to a family of polyglutamine induced neurodegenerative disorders. Transgenic mice that overexpress a mutant allele of the SCA1 gene develop a progressive ataxia and Purkinje cell pathology. In this report, the pathological importance of a segment of ataxin-1 previously shown to be important for protein-protein interactions was examined. While the absence of a 122 amino acid segment from the protein-protein interaction region of ataxin-1 did not effect the initiation of disease, its absence substantially suppressed the progression of disease in SCA1 transgenic mice. Thus, these data suggest that this region of ataxin-1 has a role in disease progression. Furthermore, these results provide evidence that ataxin-1-induced disease initiation and disease progression involve distinct molecular events.
引用
收藏
页码:33 / 42
页数:9
相关论文
共 50 条
  • [41] SCA1 TRANSGENIC MICE - A MODEL FOR NEURODEGENERATION CAUSED BY AN EXPANDED CAG TRINUCLEOTIDE REPEAT
    BURRIGHT, EN
    CLARK, HB
    SERVADIO, A
    MATILLA, T
    FEDDERSEN, RM
    YUNIS, WS
    DUVICK, LA
    ZOGHBI, HY
    ORR, HT
    CELL, 1995, 82 (06) : 937 - 948
  • [42] Calcium dynamics and electrophysiological properties of cerebellar Purkinje cells in SCA1 transgenic mice
    Inoue, T
    Lin, X
    Kohlmeier, KA
    Orr, HT
    Zoghbi, HY
    Ross, WN
    JOURNAL OF NEUROPHYSIOLOGY, 2001, 85 (04) : 1750 - 1760
  • [43] The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract
    Yue, S
    Serra, HG
    Zoghbi, HY
    Orr, HT
    HUMAN MOLECULAR GENETICS, 2001, 10 (01) : 25 - 30
  • [44] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Vig, Parminder J. S.
    Hearst, Scoty
    Shao, Qingmei
    Lopez, Mariper E.
    Murphy, Henry A., II
    Safaya, Eshan
    CEREBELLUM, 2011, 10 (02): : 254 - 266
  • [45] Calbindin-D28K and ataxin-1 positive cytoplasmic inclusions in cultured Purkinje cells from spinocerebellar ataxia-1 (SCA-1) transgenic mice.
    Vig, PJS
    Subramony, SH
    Qin, Z
    FASEB JOURNAL, 2000, 14 (08): : A1492 - A1492
  • [46] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Parminder J. S. Vig
    Scoty Hearst
    Qingmei Shao
    Mariper E. Lopez
    Henry A. Murphy
    Eshan Safaya
    The Cerebellum, 2011, 10 : 254 - 266
  • [47] Increased trinucleotide repeat instability with advanced maternal age In SCA1 transgenic mice.
    Kaytor, MD
    Burright, EN
    Duvick, LA
    Zoghbi, HY
    Orr, HT
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A312 - A312
  • [48] ELECTROPHYSIOLOGICAL FEATURES OF THE CENTRAL MOTOR TRACT IN SCA1, SCA2, AND MACHADO-JOSEPH DISEASE
    YOKOTA, T
    YOSHINO, A
    INABA, A
    SHIOJIRI, T
    YUASA, T
    SASAKI, H
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 327 - 328
  • [49] Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion
    Shahbazian, MD
    Orr, HT
    Zoghbi, HY
    NEUROBIOLOGY OF DISEASE, 2001, 8 (06) : 974 - 981
  • [50] Reversal of Purkinje cell pathology and motor dysfunction in conditional SCA1 transgenic mice.
    Zu, T
    Kaytor, MD
    Vierra-Green, CA
    Zoghbi, HY
    Clark, HB
    Orr, HT
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 179 - 179